Accordingly, a significant decrease of cell death (%Annexin V+/Live Dead-) in PMN+PBMC of NASH patients respect to PMNs was observed (Figure 4(b)). This evidence concerns the gene ANXA5 and metabolic dysfunction-associated steatohepatitis.